BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12939303)

  • 1. Comparison of different methods for detecting glaucomatous visual field progression.
    Vesti E; Johnson CA; Chauhan BC
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3873-9. PubMed ID: 12939303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.
    Katz J; Congdon N; Friedman DS
    Arch Ophthalmol; 1999 Sep; 117(9):1137-42. PubMed ID: 10496384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.
    Wilson MR; Kosoko O; Cowan CL; Sample PA; Johnson CA; Haynatzki G; Enger C; Crandall D
    Am J Ophthalmol; 2002 Sep; 134(3):399-405. PubMed ID: 12208252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability.
    Gillespie BW; Musch DC; Guire KE; Mills RP; Lichter PR; Janz NK; Wren PA;
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2613-20. PubMed ID: 12766064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies.
    Wilson MR
    Trans Am Ophthalmol Soc; 2002; 100():365-410. PubMed ID: 12545702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of retinal nerve fiber layer measurement by StratusOCT and GDx VCC, II: structure/function regression analysis in glaucoma.
    Leung CK; Chong KK; Chan WM; Yiu CK; Tso MY; Woo J; Tsang MK; Tse KK; Yung WH
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3702-11. PubMed ID: 16186352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods.
    Nouri-Mahdavi K; Caprioli J; Coleman AL; Hoffman D; Gaasterland D
    Arch Ophthalmol; 2005 Feb; 123(2):193-9. PubMed ID: 15710815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
    Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):547-54. PubMed ID: 15671281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of glaucomatous visual field progression identified by three progression criteria.
    Boden C; Blumenthal EZ; Pascual J; McEwan G; Weinreb RN; Medeiros F; Sample PA
    Am J Ophthalmol; 2004 Dec; 138(6):1029-36. PubMed ID: 15629296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mean deviation with AGIS and CIGTS scores in association with structural parameters in glaucomatous eyes.
    Naka M; Kanamori A; Tatsumi Y; Fujioka M; Nagai-Kusuhara A; Nakamura M; Negi A
    J Glaucoma; 2009; 18(5):379-84. PubMed ID: 19525728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical evaluation of the diagnostic accuracy of methods used to determine the progression of visual field defects in glaucoma.
    Mayama C; Araie M; Suzuki Y; Ishida K; Yamamoto T; Kitazawa Y; Shirakashi M; Abe H; Tsukamoto H; Mishima HK; Yoshimura K; Ohashi Y
    Ophthalmology; 2004 Nov; 111(11):2117-25. PubMed ID: 15522380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between asymmetric central corneal thickness and glaucomatous visual field loss within the same patient.
    Sullivan-Mee M; Gentry JM; Qualls C
    Optom Vis Sci; 2006 Jul; 83(7):516-9. PubMed ID: 16840876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methods to predict visual field progression in glaucoma.
    Nouri-Mahdavi K; Hoffman D; Ralli M; Caprioli J
    Arch Ophthalmol; 2007 Sep; 125(9):1176-81. PubMed ID: 17846355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma.
    Tanna AP; Budenz DL; Bandi J; Feuer WJ; Feldman RM; Herndon LW; Rhee DJ; Whiteside-de Vos J; Huang J; Anderson DR
    Ophthalmology; 2012 Mar; 119(3):468-73. PubMed ID: 22137043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability.
    Ophthalmology; 1994 Aug; 101(8):1445-55. PubMed ID: 7741836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.